                         SEQUENCE LISTING

<110>  Alper BioTech, LLC
 
<120>  Monoclonal Antibodies Aganist HER2 Antigens, and Uses Thereof

<130>  P33708WO00/23440.017

<150>  61/324490
<151>  2010-04-15

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  106
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  1

Gly Pro Gly Leu Ala Ala Pro Ser Gln Ser Leu Ser Ile Thr Cys Thr 
1               5                   10                  15      


Val Ser Gly Phe Ser Leu Thr Ser Tyr Val Ile Ser Trp Val Arg Gln 
            20                  25                  30          


Pro Pro Gly Lys Gly Leu Glu Trp Leu Gly Val Ile Trp Thr Gly Gly 
        35                  40                  45              


Gly Thr Asn Tyr Asn Ser Ala Leu Lys Ser Arg Leu Ser Ile Ser Lys 
    50                  55                  60                  


Asp Asn Ser Lys Ser Gln Val Ser Leu Lys Met Asn Ser Leu Gln Thr 
65                  70                  75                  80  


Asp Asp Thr Ala Arg Tyr Tyr Cys Ala Ser Leu Ser Tyr Asp Gly Phe 
                85                  90                  95      


Asp Tyr Trp Gly Gln Gly Thr Thr Val Thr 
            100                 105     


<210>  2
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  2

Gly Phe Ser Leu Thr Ser Tyr Val 
1               5               


<210>  3
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  3

Ile Trp Thr Gly Gly Gly Thr 
1               5           


<210>  4
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  4

Ala Ser Leu Ser Tyr Asp Gly Phe Asp Tyr Trp
1               5                   10  


<210>  5
<211>  105
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  5

Ile Leu Met Thr Gln Ser Pro Ala Ile Met Ser Ala Ser Pro Gly Glu 
1               5                   10                  15      


Lys Val Thr Met Thr Cys Ser Ala Ser Ser Ser Val Ser Tyr Met His 
            20                  25                  30          


Trp Tyr Gln Gln Lys Ser Gly Thr Ser Pro Lys Arg Trp Ile Tyr Asp 
        35                  40                  45              


Thr Ser Lys Leu Ala Ser Gly Val Pro Ala Arg Phe Ser Gly Ser Gly 
    50                  55                  60                  


Ser Gly Thr Ser Tyr Ser Leu Thr Ile Ser Ser Met Glu Ala Glu Asp 
65                  70                  75                  80  


Ala Ala Thr Tyr Tyr Cys Gln Gln Trp Ser Ser Asn Pro Leu Thr Phe 
                85                  90                  95      


Gly Ala Gly Thr Lys Leu Glu Ile Lys 
            100                 105 


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  6

Ser Ser Val Ser Tyr 
1               5   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  7

Gln Gln Trp Ser Ser Asn Pro Leu Thr 
1               5                   


<210>  8
<211>  318
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  8

aggacctggc ctggcggcgc cctcacagag cctgtccatc acatgcactg tctctgggtt       60

ctcattaacc agctatgtta taagttgggt tcgccagcca ccaggaaagg gtctggagtg      120

gcttggagta atatggactg gtggaggcac aaattataat tcagctctca aatccagact      180

gagcatcagc aaagacaact ccaagagtca agtttcctta aaaatgaaca gtctgcaaac      240

tgatgacaca gccaggtact actgtgccag cctttcctat gatggtttcg actactgggg      300

ccaagggacc acggtcac                                                    318


<210>  9
<211>  314
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  9

gacattctga tgacccagtc tccagcaatc atgtctgcat ctccagggga gaaggtcacc       60

atgaccrgca gtgccagmaa gtgtaagtta catgcactgg taccagcaga agtcaggcac      120

ctcccccaaa agatggattt atgacacatc camctggctt ctggagtccc tgctcgcttc      180

agtggcagtg ggtctgggac ctcttactct ctcamatcag cagcatggag gctgaagatg      240

ctgccactta ttactgccag cagtggagta gtaacccgct cacgttcggt gctgggacca      300

agctggaaat aaaa                                                        314


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  10

Leu Val Thr Tyr Asn Thr Asp Thr Phe Glu 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  11

Ser Met Pro Asn Pro Glu Gly Arg Tyr Thr 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  12

Tyr Asn Tyr Leu Ser Thr Asp Val Gly Ser 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  13

Glu Thr Leu Glu Glu Ile Thr Gly Tyr Leu 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  14

Tyr Ile Ser Ala Trp Pro Asp Ser Leu Pro 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  15

Tyr Ser Leu Thr Leu Gln Gly Leu Gly Ile 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  16

Pro Arg Glu Tyr Val Asn Ala Arg His Cys 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  17

Ala Asp Gln Cys Val Ala Cys Ala His Tyr 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic polypeptide

<400>  18

Pro Ser Gly Val Lys Pro Asp Leu Ser Tyr 
1               5                   10  


